Radiofrequency Ablation for Indeterminate Bethesda III Thyroid Nodules

Status: Recruiting
Location: See location...
Intervention Type: Procedure
Study Type: Observational
SUMMARY

The purpose of this observational chart review study is to evaluate the efficacy and safety of Radiofrequency Ablation (RFA) for treatment of indeterminate thyroid nodules before and after RFA procedure. This is a data collection study in which the investigators ask patients to give access to information generated before and after RFA treatment of their condition. The RFA procedure uses image guidance to place an electrode through the skin into the target area. In RFA, high-frequency electrical currents are passed through an electrode, creating a small region of heat to treat the lesion.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: t
View:

• Indeterminate Bethesda III nodules that have been molecularly profiled benign with either Afirma Genomic Sequencing Classifier (GSC) or ThyroSeq v3 tests

Locations
United States
New York
Columbia University
RECRUITING
New York
Contact Information
Primary
Jennifer H Kuo, MD MS
jhk2029@cumc.columbia.edu
212-305-6969
Backup
Catherine McManus, MD MS
cm3304@cumc.columbia.edu
212-305-6969
Time Frame
Start Date: 2020-08-01
Estimated Completion Date: 2027-08
Participants
Target number of participants: 50
Treatments
Group
Related Therapeutic Areas
Sponsors
Leads: Columbia University

This content was sourced from clinicaltrials.gov